eISSN 2329-0358


Get your full text copy in PDF

Sirolimus, A Potent New Immunosuppressive Drug For Organ Transplantation

Stanislaw M Stepkowski

Ann Transplant 1996; 1(3): 19-25

ID: 496664

Sirolimus (SRL; rapamycin, Rapamune, Wyeth-Ayerst, Princeton, NJ, USA), a macrolide antibiotic produced by the actinomycete Streptomyces hygroscopicus,was isolated from a soil sample in the Vai Atare region of Rapa Nui (Easter Island) [1]. SRL is a 31-membered macrocyclic lactone (molecular weight 914.2; CSIH79N013), which contains an unusual hemiketal masked a/p-diketo amide moiety [2].The first demonstration of SRL's anticandidal and tumoricidal activities was subsequently superseded by the discovery of the drug's potent immunosuppressive effects on allograft rejection [3-6]. However, the mosacteristic of Socumentation of its potent synergism with cyclosporine (CsA; Sandoz, Basel, Switzerland). Studies of the mechanism of action of SRL and CsA in T cells helped to increase the understanding of these drugs' synergism [7].

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree